Lifetime Omics Awarded SBIR Phase I Contract from NIAID

We are thrilled to announce that Lifetime Omics has been awarded an SBIR Phase I contract by The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) under Topic 123.

Topic Description: SBIR PHASE I – TOPIC 123: This broad topic includes investments in data resources and repositories, development of computational tools, their use, and tools to enhance timely data sharing and adherence to FAIR Data Principles (Findable, Accessible, Interoperable, and Reusable).

Awarding / Funding Agency: The National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH

Research Type: Small Business Innovation Research Program (SBIR) Phase I

This contract represents an incredible opportunity for us at Lifetime Omics to continue our commitment to advancing scientific research in the life sciences through the development of a groundbreaking data management and data sharing technology, FAIRLYZ, that promotes scientific collaborations and AI-based research.

We are grateful for the support from NIAID and look forward to leveraging this opportunity to drive advancements that will make a meaningful impact in health care.